Manuel Battegay Swiss infectiologist
Battegay, Manuel
Battegay, Manuel 1960-
VIAF ID: 5241149068371665730003 (Personal)
Permalink: http://viaf.org/viaf/5241149068371665730003
Preferred Forms
- 100 1 _ ‡a Battegay, Manuel
-
- 100 1 _ ‡a Battegay, Manuel
-
-
- 100 1 _ ‡a Battegay, Manuel
- 100 1 _ ‡a Battegay, Manuel ‡d 1960-
- 100 0 _ ‡a Manuel Battegay ‡c Swiss infectiologist
4xx's: Alternate Name Forms (4)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Aids in Basel vom Sterben an Aids zum Leben mit HIV | |
Epidemiologie von HIV | |
HIV-Infektion : wann ist eine antiretrovirale Therapie indiziert? | |
Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition | |
Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection | |
Improved services to enrollees into an HIV rural care and treatment center in Tanzania | |
Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study | |
Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection | |
Incidence and risk factors for hypertension among HIV patients in rural Tanzania - A prospective cohort study | |
Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013. | |
Increased Epstein-Barr virus-specific antibody-levels in HIV-infected individuals developing primary central nervous system lymphoma | |
Increasing prevalence of infectious diseases in asylum seekers at a tertiary care hospital in Switzerland | |
Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort Study | |
Inflammatory bowel perforation during immune restoration after one year of antiretroviral and antituberculous therapy in an HIV-1-infected patient: report of a case | |
Initial patient assessment of infectious diseases and diagnostic steps with fever | |
Interactions of the hepatitis C virus protease inhibitor faldaprevir with cytochrome P450 enzymes: in vitro and in vivo correlation | |
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy | |
Internistische Notfälle sicher durch die Akutsituation und die nachfolgenden 48 Stunden ; 82 Tabellen | |
Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death. | |
Intranasal Influenza Vaccine in a Working Population | |
Intravenous opiate maintenance in a cohort of injecting drug addicts | |
Is switching to an oral antibiotic regimen safe after 2 weeks of intravenous treatment for primary bacterial vertebral osteomyelitis? | |
Is unsafe sexual behaviour increasing among HIV-infected individuals? | |
JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy | |
Klinische Infektiologie Infektionskrankheiten erkennen und behandeln ; mit 253 Tabellen | |
Knowing one's medical fate in advance : challenges for diagnosis and treatment, philosophy, ethics and religion | |
Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population | |
Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006. | |
Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared | |
Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection | |
Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland | |
Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study | |
Low-Dose Acetylsalicylic Acid Treatment and Impact on Short-Term Mortality in Staphylococcus aureus Bloodstream Infection: A Propensity Score-Matched Cohort Study | |
Low doses of zidovudine plus didanosine are less effective than higher doses of didanosine monotherapy: a randomized trial in patients pretreated with zidovudine | |
Low levels of mannan-binding lectin or ficolins are not associated with an increased risk of cytomegalovirus disease in HIV-infected patients | |
Low postseroconversion CD4 count and rapid decrease of CD4 density identify HIV+ fast progressors. | |
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection | |
Meta-analysis of randomized controlled trials of simplified versus continued protease inhibitor-based antiretroviral therapy in HIV-1-infected patients | |
Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival | |
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders | |
Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland | |
Morbidity and mortality in HIV-infected individuals - a shift towards comorbidities | |
Moving up from 3 by 5. | |
Mycobacterium tuberculosis transmission in a country with low tuberculosis incidence: role of immigration and HIV infection | |
Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study | |
Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection | |
Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians | |
Outcomes of early switching from intravenous to oral antibiotics on medical wards | |
Persistent apoptosis in HIV-1-infected individuals receiving potent antiretroviral therapy is associated with poor recovery of CD4 T lymphocytes | |
Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load | |
Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication | |
Postoperative wound infections: essentials for the internal medicine | |
Potential benefit and limitations of a broad access to potent antiretroviral therapy in developing countries | |
Predictive value of adherence in patients starting highly active antiretroviral treatment for HIV infection. | |
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study | |
Prevalence and Evolution of Renal Impairment in People Living With HIV in Rural Tanzania | |
Prevalence and Outcomes of Hepatitis B Coinfection and Associated Liver Disease Among Antiretroviral Therapy-Naive Individuals in a Rural Tanzanian Human Immunodeficiency Virus Cohort | |
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study | |
Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study | |
Prevention of mother-to-child transmission of HIV Option B+ cascade in rural Tanzania: The One Stop Clinic model | |
Previous exposure in a high-risk area for travellers' diarrhoea within the past year is associated with a significant protective effect for travellers' diarrhoea: a prospective observational cohort study in travellers to South Asia | |
Prior therapy influences the efficacy of lamivudine monotherapy in patients with lamivudine-resistant HIV-1 infection | |
Productivity costs and determinants of productivity in HIV-infected patients. | |
Prospective study of a panfungal PCR assay followed by sequencing, for the detection of fungal DNA in normally sterile specimens in a clinical setting: a complementary tool in the diagnosis of invasive fungal disease? | |
Protease inhibitor-sparing simplified maintenance therapy: a need for perspective | |
[Psychosocial aspects on the treatment of HIV-infection]. | |
Psychosoziale Aspekte bei der Behandlung der HIV-Infektion | |
Pulmonary infections diagnosed by BAL: a 12-year experience in 1066 immunocompromised patients. | |
Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 well plates | |
Reasons for late presentation to HIV care in Switzerland | |
Rectal swab for detection of norovirus by real-time PCR: similar sensitivity compared to faecal specimens | |
Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir | |
Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort Study | |
Response to combination antiretroviral therapy: variation by age. | |
Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study | |
Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS). | |
Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo | |
Round-table multidisciplinary counselling of couples with HIV prior to assisted reproduction. | |
Safety and efficacy of once-daily nevirapine dosing: a multicohort study | |
Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. Swiss HIV Cohort Study. | |
Scabies outbreak in an intensive care unit with 1,659 exposed individuals--key factors for controlling the outbreak | |
A smoking cessation programme in HIV-infected individuals: a pilot study. |